Project Y Biotech was founded in Southern California in 2023 to fill a need in the Regenerative Biotech industry for a better model of client interaction and enhanced clinical end-points. With an extensive background of experience in production and distribution, we identified gaps in the protocols between products used in clinical studies compared to the commercial space – in other words, we wanted to be able to provide products that can actually produce the results that Physicians (and the public) read about in journal articles. Through various strategic alignments and collaborations, we have created a line of products that answer the bell for those who are looking to actually mimic clinical study outcomes and elicit responses that can be truly life-changing.

Our lab is cGMP certified and compliant with all FDA requirements for processing human tissue allografts. Our tissue bank partner is FDA and AATB compliant and has extensive history working in this space for both commercial and research applications. They are Missouri-based and harvest donated tissue from planned c-section births from three contracted hospitals in the St. Louis area so that there is no need for processing or freezing of the tissue in advance of arrival to their facility. Project Y Biotech is an FDA Registered manufacturer providing a menu of advanced options for a select clientele, both in the United States an abroad.